Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir A Razmjou

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Culture, Medicine and Psychiatry|March 25, 2020
A Troubling NotificationAmir A Razmjou
Cureus|March 3, 2025
Crowned Dens Syndrome Presenting as Failure to Thrive in a Patient With Moderate Cognitive ImpairmentGustavo Castellanos, Gregory L Stone, Amir A Razmjou
Clinical Rheumatology|September 22, 2022
Suppressed paraoxonase-1 activity associates with elevated oxylipins and the presence of small airways disease in patients with rheumatoid arthritisAmir A Razmjou, Jennifer M Wang, Ani Shahbazian, et al.
Cureus|January 1, 2020
A Case of Granulomatosis with Polyangiitis: Consequences of Delayed Diagnosis in a Life-threatening MaladyAmir A Razmjou, Young-Ji Seo, Michael F Ayoub, et al.
BMC Rheumatology|October 22, 2020
Ultrasound and multi-biomarker disease activity score for assessing and predicting clinical response to tofacitinib treatment in patients with rheumatoid arthritisAmir A Razmjou, Jenny Brook, David Elashoff, et al.
RMD Open|October 26, 2024
Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipinsAmir A Razmjou, Joel M Kremer, Dimitrios A Pappas, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Culture, Medicine and Psychiatry|March 25, 2020
A Troubling NotificationAmir A Razmjou
Cureus|March 3, 2025
Crowned Dens Syndrome Presenting as Failure to Thrive in a Patient With Moderate Cognitive ImpairmentGustavo Castellanos, Gregory L Stone, Amir A Razmjou
Clinical Rheumatology|September 22, 2022
Suppressed paraoxonase-1 activity associates with elevated oxylipins and the presence of small airways disease in patients with rheumatoid arthritisAmir A Razmjou, Jennifer M Wang, Ani Shahbazian, et al.
Cureus|January 1, 2020
A Case of Granulomatosis with Polyangiitis: Consequences of Delayed Diagnosis in a Life-threatening MaladyAmir A Razmjou, Young-Ji Seo, Michael F Ayoub, et al.
BMC Rheumatology|October 22, 2020
Ultrasound and multi-biomarker disease activity score for assessing and predicting clinical response to tofacitinib treatment in patients with rheumatoid arthritisAmir A Razmjou, Jenny Brook, David Elashoff, et al.
RMD Open|October 26, 2024
Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipinsAmir A Razmjou, Joel M Kremer, Dimitrios A Pappas, et al.
Pageof 1